What are the brand names for estrogen (estradiol) patches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Names for Estrogen Patches

The most commonly available estrogen (estradiol) transdermal patches include Climara (once-weekly application), Estraderm/Estraderm MX (twice-weekly application), Vivelle-Dot, Alora, and Minivelle, with Climara being extensively studied for its 7-day wear period and superior adhesion properties. 1, 2

Primary Estrogen Patch Brands

Once-Weekly Patches

  • Climara is a 7-day estradiol transdermal system available in 0.05 mg/day and 0.1 mg/day doses, utilizing drug-in-adhesive matrix technology 1, 2
  • Climara delivers sustained estradiol blood levels for the full 7 days of patch wear, maintaining a physiologic estrone to estradiol ratio without drug accumulation 1
  • Clinical studies demonstrate that Climara has excellent adhesion properties, significantly better than Estraderm, while maintaining similar skin irritation profiles 1, 2

Twice-Weekly Patches

  • Estraderm and Estraderm MX are matrix patches delivering 0.05 mg estradiol per day, applied twice weekly for 12-week treatment cycles 3
  • Estraderm MX 50 has been shown to significantly reduce moderate to severe hot flushes compared to placebo (P < 0.001) with low rates of skin irritation 3
  • Menorest is another matrix system with 3-4 days of suggested use, available in 50 mcg/24h dosing 4

Important Clinical Distinctions

Contraceptive vs. Hormone Replacement Patches

  • Ortho Evra is specifically a combination hormone contraceptive patch containing norelgestromin (progestin) and ethinyl estradiol, not pure estradiol for hormone replacement 5, 6
  • Ortho Evra delivers approximately 150 mcg of norelgestromin and 35 mcg of ethinyl estradiol daily, with 1.6 times higher estrogen exposure than low-dose combined oral contraceptives 5, 6
  • The contraceptive patch has an increased risk of venous thromboembolism compared to other hormonal methods and may be less effective in women weighing more than 198 pounds 5, 6

Application Site Considerations

Optimal Placement for Estradiol Patches

  • Estradiol patches should be applied to the abdomen, upper torso, upper outer arm, or buttocks 5
  • The buttock provides higher and more consistent absorption of estradiol compared to the abdomen, with mean peak plasma concentration 125.1% and mean relative bioavailability 117.2% of abdominal application 7
  • Buttock application may provide an advantage for women experiencing breakthrough menopausal symptoms at the end of the week 7

Comparative Bioavailability

Patch-to-Patch Differences

  • Menorest and Climara (both 50 mcg/24h) show similar bioavailability of estradiol, though they are not bioequivalent due to significantly shorter Tmax for Menorest 4
  • Both 0.05 mg and 0.1 mg Climara patches demonstrate dose proportionality in pharmacokinetic studies 1

References

Research

Clinical experience with a 7-day estrogen patch: principles and practice.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraceptive Patch Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.